Free Trial
LON:CNSL

Cambridge Nutritional Sciences Interim Earnings Results & Report

GBX 1.51 0.00 (0.00%)
As of 07:14 AM Eastern

Cambridge Nutritional Sciences reported Interim earnings on November 21, 2024. The company reported EPS of -GBX 0.10.

Earnings Announcement Details

Quarter
Interim
Time
After Market Closes

Cambridge Nutritional Sciences EPS Results

Actual EPS
-GBX 0.10
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Cambridge Nutritional Sciences Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Cambridge Nutritional Sciences Interim Earnings FAQ

Cambridge Nutritional Sciences (LON:CNSL) reported earnings of -GBX 0.10 per share for Interim. The report was announced on Thursday, November 21, 2024.

Cambridge Nutritional Sciences Earnings Headlines

Free Ticker: Anthropic's silent partner could soar after record $2 trillion IPO
Anthropic's IPO prospectus just leaked, revealing 261 pages tied to a record $2 trillion valuation. Beyond headline backers Amazon and Google, tech analyst Matt McCall has tracked a smaller partner that got in early, before most investors knew Claude existed. Matt calls it a Second IPO opportunity and reveals its name and ticker in a free interview.tc pixel
See More Cambridge Nutritional Sciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cambridge Nutritional Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cambridge Nutritional Sciences and other key companies, straight to your email.

About Cambridge Nutritional Sciences

Cambridge Nutritional Sciences (LON:CNSL) (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.

View Cambridge Nutritional Sciences Profile